Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy

PURPOSE: Reactive oxygen species modulator 1 (Romo1) is a key mediator of intracellular reactive oxygen species production. However, examination of the clinical usefulness of Romo1 in cancers has been limited. We evaluated the association of Romo1 expression with clinical outcomes in advanced non-sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Hyeun, Choi, Sue In, Lee, Ji Sung, Kim, Chul Hwan, Jung, Won Jai, Lee, Eun Joo, Min, Kyung Hoon, Hur, Gyu Young, Lee, Seung Heon, Lee, Sung Yong, Kim, Je Hyeong, Lee, Sang Yeub, Shin, Chol, Shim, Jae Jeong, Kang, Kyung Ho, In, Kwang Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266402/
https://www.ncbi.nlm.nih.gov/pubmed/27188201
http://dx.doi.org/10.4143/crt.2016.133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266402/
https://www.ncbi.nlm.nih.gov/pubmed/27188201
http://dx.doi.org/10.4143/crt.2016.133

Ejemplares similares